SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.
Squamous cell carcinoma (SCC) of the lung is a frequent and aggressive cancer type. Gene amplifications, a known activating mechanism of oncogenes, target the 3q26-qter region as one of the most frequently gained/amplified genomic sites in SCC of various types. Here, we used array comparative genomi...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2010
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/a3b2ea6dd9484143b1b61997e717f532 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:a3b2ea6dd9484143b1b61997e717f532 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:a3b2ea6dd9484143b1b61997e717f5322021-11-25T06:26:16ZSOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.1932-620310.1371/journal.pone.0008960https://doaj.org/article/a3b2ea6dd9484143b1b61997e717f5322010-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20126410/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Squamous cell carcinoma (SCC) of the lung is a frequent and aggressive cancer type. Gene amplifications, a known activating mechanism of oncogenes, target the 3q26-qter region as one of the most frequently gained/amplified genomic sites in SCC of various types. Here, we used array comparative genomic hybridization to delineate the consensus region of 3q26.3 amplifications in lung SCC. Recurrent amplifications occur in 20% of lung SCC (136 tumors in total) and map to a core region of 2 Mb (Megabases) that encompasses SOX2, a transcription factor gene. Intense SOX2 immunostaining is frequent in nuclei of lung SCC, indicating potential active transcriptional regulation by SOX2. Analyses of the transcriptome of lung SCC, SOX2-overexpressing lung epithelial cells and embryonic stem cells (ESCs) reveal that SOX2 contributes to activate ESC-like phenotypes and provide clues pertaining to the deregulated genes involved in the malignant phenotype. In cell culture experiments, overexpression of SOX2 stimulates cellular migration and anchorage-independent growth while SOX2 knockdown impairs cell growth. Finally, SOX2 over-expression in non-tumorigenic human lung bronchial epithelial cells is tumorigenic in immunocompromised mice. These results indicate that the SOX2 transcription factor, a major regulator of stem cell function, is also an oncogene and a driver gene for the recurrent 3q26.33 amplifications in lung SCC.Thomas HussenetSoraya DaliJulien ExingerBen MongaBernard JostDoulaye DembeléNadine MartinetChristelle ThibaultJoerg HuelskenElisabeth BrambillaStanislas du ManoirPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 1, p e8960 (2010) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Thomas Hussenet Soraya Dali Julien Exinger Ben Monga Bernard Jost Doulaye Dembelé Nadine Martinet Christelle Thibault Joerg Huelsken Elisabeth Brambilla Stanislas du Manoir SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. |
| description |
Squamous cell carcinoma (SCC) of the lung is a frequent and aggressive cancer type. Gene amplifications, a known activating mechanism of oncogenes, target the 3q26-qter region as one of the most frequently gained/amplified genomic sites in SCC of various types. Here, we used array comparative genomic hybridization to delineate the consensus region of 3q26.3 amplifications in lung SCC. Recurrent amplifications occur in 20% of lung SCC (136 tumors in total) and map to a core region of 2 Mb (Megabases) that encompasses SOX2, a transcription factor gene. Intense SOX2 immunostaining is frequent in nuclei of lung SCC, indicating potential active transcriptional regulation by SOX2. Analyses of the transcriptome of lung SCC, SOX2-overexpressing lung epithelial cells and embryonic stem cells (ESCs) reveal that SOX2 contributes to activate ESC-like phenotypes and provide clues pertaining to the deregulated genes involved in the malignant phenotype. In cell culture experiments, overexpression of SOX2 stimulates cellular migration and anchorage-independent growth while SOX2 knockdown impairs cell growth. Finally, SOX2 over-expression in non-tumorigenic human lung bronchial epithelial cells is tumorigenic in immunocompromised mice. These results indicate that the SOX2 transcription factor, a major regulator of stem cell function, is also an oncogene and a driver gene for the recurrent 3q26.33 amplifications in lung SCC. |
| format |
article |
| author |
Thomas Hussenet Soraya Dali Julien Exinger Ben Monga Bernard Jost Doulaye Dembelé Nadine Martinet Christelle Thibault Joerg Huelsken Elisabeth Brambilla Stanislas du Manoir |
| author_facet |
Thomas Hussenet Soraya Dali Julien Exinger Ben Monga Bernard Jost Doulaye Dembelé Nadine Martinet Christelle Thibault Joerg Huelsken Elisabeth Brambilla Stanislas du Manoir |
| author_sort |
Thomas Hussenet |
| title |
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. |
| title_short |
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. |
| title_full |
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. |
| title_fullStr |
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. |
| title_full_unstemmed |
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. |
| title_sort |
sox2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2010 |
| url |
https://doaj.org/article/a3b2ea6dd9484143b1b61997e717f532 |
| work_keys_str_mv |
AT thomashussenet sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT sorayadali sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT julienexinger sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT benmonga sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT bernardjost sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT doulayedembele sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT nadinemartinet sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT christellethibault sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT joerghuelsken sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT elisabethbrambilla sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas AT stanislasdumanoir sox2isanoncogeneactivatedbyrecurrent3q263amplificationsinhumanlungsquamouscellcarcinomas |
| _version_ |
1718413761197375488 |